✦ LIBER ✦

P.3.023 A double-blind, placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder

✍ Scribed by H.G.M. Westenberg; D.J. Stein; H. Yang; D. Li; L.M. Barbato

Book ID: 119577178
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 141 KB
Volume: 13
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(03)92143-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychopharmacological treatment of socia

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

✍ Irene M. Vliet; Johan A. Boer; Herman G. M. Westenberg 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 955 KB

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Deramciclane in the treatment of general

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

✍ Y. Lecrubier; A. J. Puech; A. Azcona; P. E. Bailey; X. Lataste 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 594 KB

Fluvoxamine in the treatment of panic di

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

✍ Gregory M Asnis; Faiq A Hameedi; Andrew W Goddard; Steven G Potkin; Donald Black 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage